nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—ADRB1—stomach cancer	0.484	0.543	CbGaD
Metipranolol—ADRB2—stomach cancer	0.407	0.457	CbGaD
Metipranolol—Lacrimation—Floxuridine—stomach cancer	0.00605	0.0603	CcSEcCtD
Metipranolol—Lacrimation increased—Floxuridine—stomach cancer	0.00386	0.0384	CcSEcCtD
Metipranolol—Photophobia—Floxuridine—stomach cancer	0.00334	0.0333	CcSEcCtD
Metipranolol—Angina pectoris—Floxuridine—stomach cancer	0.00218	0.0217	CcSEcCtD
Metipranolol—Lacrimation—Irinotecan—stomach cancer	0.00206	0.0205	CcSEcCtD
Metipranolol—Lacrimation—Fluorouracil—stomach cancer	0.00198	0.0197	CcSEcCtD
Metipranolol—Blepharitis—Fluorouracil—stomach cancer	0.00189	0.0188	CcSEcCtD
Metipranolol—Epistaxis—Floxuridine—stomach cancer	0.00188	0.0187	CcSEcCtD
Metipranolol—Lacrimation—Docetaxel—stomach cancer	0.00143	0.0142	CcSEcCtD
Metipranolol—Lacrimation increased—Irinotecan—stomach cancer	0.00132	0.0131	CcSEcCtD
Metipranolol—Discomfort—Floxuridine—stomach cancer	0.00131	0.013	CcSEcCtD
Metipranolol—Lacrimation increased—Fluorouracil—stomach cancer	0.00126	0.0125	CcSEcCtD
Metipranolol—Vision blurred—Mitomycin—stomach cancer	0.00115	0.0115	CcSEcCtD
Metipranolol—Photophobia—Fluorouracil—stomach cancer	0.00109	0.0109	CcSEcCtD
Metipranolol—Cough—Mitomycin—stomach cancer	0.00107	0.0106	CcSEcCtD
Metipranolol—Hypertension—Mitomycin—stomach cancer	0.00105	0.0105	CcSEcCtD
Metipranolol—Discomfort—Mitomycin—stomach cancer	0.00103	0.0102	CcSEcCtD
Metipranolol—Oedema—Mitomycin—stomach cancer	0.000996	0.00992	CcSEcCtD
Metipranolol—Lacrimation—Epirubicin—stomach cancer	0.000962	0.00958	CcSEcCtD
Metipranolol—Hypersensitivity—Floxuridine—stomach cancer	0.000936	0.00931	CcSEcCtD
Metipranolol—Asthenia—Floxuridine—stomach cancer	0.000911	0.00907	CcSEcCtD
Metipranolol—Lacrimation increased—Docetaxel—stomach cancer	0.00091	0.00906	CcSEcCtD
Metipranolol—Lacrimation—Doxorubicin—stomach cancer	0.00089	0.00886	CcSEcCtD
Metipranolol—Dyspnoea—Mitomycin—stomach cancer	0.000888	0.00884	CcSEcCtD
Metipranolol—Somnolence—Mitomycin—stomach cancer	0.000886	0.00882	CcSEcCtD
Metipranolol—Lacrimation increased—Capecitabine—stomach cancer	0.000881	0.00877	CcSEcCtD
Metipranolol—Practolol—ADRB1—stomach cancer	0.000827	0.102	CrCbGaD
Metipranolol—Rash—Floxuridine—stomach cancer	0.000801	0.00797	CcSEcCtD
Metipranolol—Dermatitis—Floxuridine—stomach cancer	0.0008	0.00796	CcSEcCtD
Metipranolol—Headache—Floxuridine—stomach cancer	0.000795	0.00792	CcSEcCtD
Metipranolol—Nausea—Floxuridine—stomach cancer	0.000754	0.00751	CcSEcCtD
Metipranolol—Angina pectoris—Irinotecan—stomach cancer	0.000741	0.00738	CcSEcCtD
Metipranolol—Asthenia—Mitomycin—stomach cancer	0.000715	0.00712	CcSEcCtD
Metipranolol—Angina pectoris—Fluorouracil—stomach cancer	0.00071	0.00707	CcSEcCtD
Metipranolol—Abnormal vision—Capecitabine—stomach cancer	0.000708	0.00705	CcSEcCtD
Metipranolol—Acute coronary syndrome—Irinotecan—stomach cancer	0.000669	0.00666	CcSEcCtD
Metipranolol—Myocardial infarction—Irinotecan—stomach cancer	0.000665	0.00662	CcSEcCtD
Metipranolol—Dizziness—Mitomycin—stomach cancer	0.000659	0.00656	CcSEcCtD
Metipranolol—Atrial fibrillation—Docetaxel—stomach cancer	0.000642	0.00639	CcSEcCtD
Metipranolol—Acute coronary syndrome—Fluorouracil—stomach cancer	0.000641	0.00638	CcSEcCtD
Metipranolol—Myocardial infarction—Fluorouracil—stomach cancer	0.000637	0.00634	CcSEcCtD
Metipranolol—Conjunctivitis—Fluorouracil—stomach cancer	0.000632	0.00629	CcSEcCtD
Metipranolol—Rash—Mitomycin—stomach cancer	0.000628	0.00625	CcSEcCtD
Metipranolol—Dermatitis—Mitomycin—stomach cancer	0.000628	0.00625	CcSEcCtD
Metipranolol—Headache—Mitomycin—stomach cancer	0.000624	0.00621	CcSEcCtD
Metipranolol—Atrial fibrillation—Capecitabine—stomach cancer	0.000622	0.00619	CcSEcCtD
Metipranolol—Bradycardia—Irinotecan—stomach cancer	0.00062	0.00617	CcSEcCtD
Metipranolol—Lacrimation increased—Epirubicin—stomach cancer	0.000614	0.00611	CcSEcCtD
Metipranolol—Epistaxis—Fluorouracil—stomach cancer	0.000613	0.0061	CcSEcCtD
Metipranolol—Rhinitis—Irinotecan—stomach cancer	0.000611	0.00608	CcSEcCtD
Metipranolol—Arthritis—Capecitabine—stomach cancer	0.000606	0.00604	CcSEcCtD
Metipranolol—Esmolol—ADRB1—stomach cancer	0.000594	0.073	CrCbGaD
Metipranolol—Nausea—Mitomycin—stomach cancer	0.000592	0.00589	CcSEcCtD
Metipranolol—Visual impairment—Irinotecan—stomach cancer	0.000587	0.00584	CcSEcCtD
Metipranolol—Rhinitis—Fluorouracil—stomach cancer	0.000585	0.00582	CcSEcCtD
Metipranolol—Lacrimation increased—Doxorubicin—stomach cancer	0.000568	0.00565	CcSEcCtD
Metipranolol—Atenolol—ADRB1—stomach cancer	0.000518	0.0637	CrCbGaD
Metipranolol—Angina pectoris—Docetaxel—stomach cancer	0.000512	0.0051	CcSEcCtD
Metipranolol—Esmolol—ADRB2—stomach cancer	0.0005	0.0614	CrCbGaD
Metipranolol—Angina pectoris—Capecitabine—stomach cancer	0.000496	0.00494	CcSEcCtD
Metipranolol—Abnormal vision—Epirubicin—stomach cancer	0.000493	0.00491	CcSEcCtD
Metipranolol—Bronchitis—Capecitabine—stomach cancer	0.00049	0.00488	CcSEcCtD
Metipranolol—Vision blurred—Fluorouracil—stomach cancer	0.000479	0.00476	CcSEcCtD
Metipranolol—Acebutolol—ADRB1—stomach cancer	0.000478	0.0587	CrCbGaD
Metipranolol—Oxprenolol—ADRB1—stomach cancer	0.000475	0.0583	CrCbGaD
Metipranolol—Cough—Irinotecan—stomach cancer	0.000463	0.00461	CcSEcCtD
Metipranolol—Acute coronary syndrome—Docetaxel—stomach cancer	0.000462	0.0046	CcSEcCtD
Metipranolol—Myocardial infarction—Docetaxel—stomach cancer	0.00046	0.00458	CcSEcCtD
Metipranolol—Hypertension—Irinotecan—stomach cancer	0.000458	0.00456	CcSEcCtD
Metipranolol—Abnormal vision—Doxorubicin—stomach cancer	0.000456	0.00454	CcSEcCtD
Metipranolol—Conjunctivitis—Docetaxel—stomach cancer	0.000456	0.00454	CcSEcCtD
Metipranolol—Acute coronary syndrome—Capecitabine—stomach cancer	0.000448	0.00446	CcSEcCtD
Metipranolol—Discomfort—Irinotecan—stomach cancer	0.000446	0.00444	CcSEcCtD
Metipranolol—Myocardial infarction—Capecitabine—stomach cancer	0.000445	0.00443	CcSEcCtD
Metipranolol—Epistaxis—Docetaxel—stomach cancer	0.000442	0.0044	CcSEcCtD
Metipranolol—Conjunctivitis—Capecitabine—stomach cancer	0.000441	0.00439	CcSEcCtD
Metipranolol—Atenolol—ADRB2—stomach cancer	0.000436	0.0535	CrCbGaD
Metipranolol—Alprenolol—ADRB1—stomach cancer	0.000434	0.0533	CrCbGaD
Metipranolol—Oedema—Irinotecan—stomach cancer	0.000433	0.00431	CcSEcCtD
Metipranolol—Myalgia—Fluorouracil—stomach cancer	0.000432	0.0043	CcSEcCtD
Metipranolol—Epistaxis—Capecitabine—stomach cancer	0.000428	0.00426	CcSEcCtD
Metipranolol—Discomfort—Fluorouracil—stomach cancer	0.000427	0.00425	CcSEcCtD
Metipranolol—Rhinitis—Docetaxel—stomach cancer	0.000422	0.0042	CcSEcCtD
Metipranolol—Bradycardia—Capecitabine—stomach cancer	0.000415	0.00413	CcSEcCtD
Metipranolol—Oedema—Fluorouracil—stomach cancer	0.000414	0.00413	CcSEcCtD
Metipranolol—Rhinitis—Capecitabine—stomach cancer	0.000409	0.00407	CcSEcCtD
Metipranolol—Visual impairment—Docetaxel—stomach cancer	0.000406	0.00404	CcSEcCtD
Metipranolol—Metoprolol—ADRB1—stomach cancer	0.000404	0.0496	CrCbGaD
Metipranolol—Acebutolol—ADRB2—stomach cancer	0.000402	0.0494	CrCbGaD
Metipranolol—Oxprenolol—ADRB2—stomach cancer	0.000399	0.049	CrCbGaD
Metipranolol—Visual impairment—Capecitabine—stomach cancer	0.000393	0.00391	CcSEcCtD
Metipranolol—Alprenolol—HTR1A—stomach cancer	0.000389	0.0477	CrCbGaD
Metipranolol—Dyspnoea—Irinotecan—stomach cancer	0.000386	0.00384	CcSEcCtD
Metipranolol—Somnolence—Irinotecan—stomach cancer	0.000385	0.00383	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000378	0.00376	CcSEcCtD
Metipranolol—Pindolol—ADRB1—stomach cancer	0.000374	0.0459	CrCbGaD
Metipranolol—Dyspnoea—Fluorouracil—stomach cancer	0.000369	0.00368	CcSEcCtD
Metipranolol—Somnolence—Fluorouracil—stomach cancer	0.000368	0.00367	CcSEcCtD
Metipranolol—Alprenolol—ADRB2—stomach cancer	0.000365	0.0449	CrCbGaD
Metipranolol—Angina pectoris—Epirubicin—stomach cancer	0.000346	0.00344	CcSEcCtD
Metipranolol—Bronchitis—Epirubicin—stomach cancer	0.000341	0.0034	CcSEcCtD
Metipranolol—Metoprolol—ADRB2—stomach cancer	0.00034	0.0417	CrCbGaD
Metipranolol—Vision blurred—Capecitabine—stomach cancer	0.000334	0.00333	CcSEcCtD
Metipranolol—Pindolol—HTR1A—stomach cancer	0.000334	0.0411	CrCbGaD
Metipranolol—Conjunctivitis—Methotrexate—stomach cancer	0.000329	0.00327	CcSEcCtD
Metipranolol—Palpitations—Docetaxel—stomach cancer	0.000324	0.00322	CcSEcCtD
Metipranolol—Cough—Docetaxel—stomach cancer	0.00032	0.00318	CcSEcCtD
Metipranolol—Angina pectoris—Doxorubicin—stomach cancer	0.00032	0.00318	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—stomach cancer	0.000319	0.00317	CcSEcCtD
Metipranolol—Hypersensitivity—Irinotecan—stomach cancer	0.000319	0.00317	CcSEcCtD
Metipranolol—Hypertension—Docetaxel—stomach cancer	0.000316	0.00315	CcSEcCtD
Metipranolol—Bronchitis—Doxorubicin—stomach cancer	0.000316	0.00314	CcSEcCtD
Metipranolol—Pindolol—ADRB2—stomach cancer	0.000314	0.0386	CrCbGaD
Metipranolol—Palpitations—Capecitabine—stomach cancer	0.000314	0.00312	CcSEcCtD
Metipranolol—Myalgia—Docetaxel—stomach cancer	0.000312	0.00311	CcSEcCtD
Metipranolol—Asthenia—Irinotecan—stomach cancer	0.00031	0.00309	CcSEcCtD
Metipranolol—Cough—Capecitabine—stomach cancer	0.00031	0.00308	CcSEcCtD
Metipranolol—Conjunctivitis—Epirubicin—stomach cancer	0.000307	0.00306	CcSEcCtD
Metipranolol—Hypertension—Capecitabine—stomach cancer	0.000306	0.00305	CcSEcCtD
Metipranolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000305	0.00304	CcSEcCtD
Metipranolol—Myalgia—Capecitabine—stomach cancer	0.000302	0.00301	CcSEcCtD
Metipranolol—Anxiety—Capecitabine—stomach cancer	0.000301	0.003	CcSEcCtD
Metipranolol—Oedema—Docetaxel—stomach cancer	0.000299	0.00298	CcSEcCtD
Metipranolol—Discomfort—Capecitabine—stomach cancer	0.000298	0.00297	CcSEcCtD
Metipranolol—Epistaxis—Epirubicin—stomach cancer	0.000298	0.00297	CcSEcCtD
Metipranolol—Visual impairment—Methotrexate—stomach cancer	0.000292	0.00291	CcSEcCtD
Metipranolol—Oedema—Capecitabine—stomach cancer	0.00029	0.00288	CcSEcCtD
Metipranolol—Bradycardia—Epirubicin—stomach cancer	0.000289	0.00288	CcSEcCtD
Metipranolol—Dizziness—Irinotecan—stomach cancer	0.000286	0.00285	CcSEcCtD
Metipranolol—Rhinitis—Epirubicin—stomach cancer	0.000285	0.00283	CcSEcCtD
Metipranolol—Conjunctivitis—Doxorubicin—stomach cancer	0.000285	0.00283	CcSEcCtD
Metipranolol—Epistaxis—Doxorubicin—stomach cancer	0.000276	0.00275	CcSEcCtD
Metipranolol—Dizziness—Fluorouracil—stomach cancer	0.000274	0.00273	CcSEcCtD
Metipranolol—Visual impairment—Epirubicin—stomach cancer	0.000274	0.00272	CcSEcCtD
Metipranolol—Rash—Irinotecan—stomach cancer	0.000273	0.00272	CcSEcCtD
Metipranolol—Dermatitis—Irinotecan—stomach cancer	0.000273	0.00271	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000273	0.00271	CcSEcCtD
Metipranolol—Headache—Irinotecan—stomach cancer	0.000271	0.0027	CcSEcCtD
Metipranolol—Bradycardia—Doxorubicin—stomach cancer	0.000268	0.00266	CcSEcCtD
Metipranolol—Dyspnoea—Docetaxel—stomach cancer	0.000267	0.00266	CcSEcCtD
Metipranolol—Somnolence—Docetaxel—stomach cancer	0.000266	0.00265	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000264	0.00263	CcSEcCtD
Metipranolol—Rhinitis—Doxorubicin—stomach cancer	0.000263	0.00262	CcSEcCtD
Metipranolol—Rash—Fluorouracil—stomach cancer	0.000261	0.0026	CcSEcCtD
Metipranolol—Dermatitis—Fluorouracil—stomach cancer	0.000261	0.0026	CcSEcCtD
Metipranolol—Headache—Fluorouracil—stomach cancer	0.00026	0.00258	CcSEcCtD
Metipranolol—Dyspnoea—Capecitabine—stomach cancer	0.000258	0.00257	CcSEcCtD
Metipranolol—Nausea—Irinotecan—stomach cancer	0.000257	0.00256	CcSEcCtD
Metipranolol—Visual impairment—Doxorubicin—stomach cancer	0.000253	0.00252	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—stomach cancer	0.000249	0.00248	CcSEcCtD
Metipranolol—Nausea—Fluorouracil—stomach cancer	0.000246	0.00245	CcSEcCtD
Metipranolol—Tension—Epirubicin—stomach cancer	0.000243	0.00242	CcSEcCtD
Metipranolol—Nervousness—Epirubicin—stomach cancer	0.00024	0.00239	CcSEcCtD
Metipranolol—Vision blurred—Epirubicin—stomach cancer	0.000233	0.00232	CcSEcCtD
Metipranolol—Cough—Methotrexate—stomach cancer	0.000231	0.0023	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—stomach cancer	0.000225	0.00224	CcSEcCtD
Metipranolol—Tension—Doxorubicin—stomach cancer	0.000224	0.00223	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—stomach cancer	0.000222	0.00221	CcSEcCtD
Metipranolol—Nervousness—Doxorubicin—stomach cancer	0.000222	0.00221	CcSEcCtD
Metipranolol—Hypersensitivity—Docetaxel—stomach cancer	0.00022	0.00219	CcSEcCtD
Metipranolol—Palpitations—Epirubicin—stomach cancer	0.000218	0.00218	CcSEcCtD
Metipranolol—Cough—Epirubicin—stomach cancer	0.000216	0.00215	CcSEcCtD
Metipranolol—Vision blurred—Doxorubicin—stomach cancer	0.000216	0.00215	CcSEcCtD
Metipranolol—Asthenia—Docetaxel—stomach cancer	0.000215	0.00214	CcSEcCtD
Metipranolol—Hypertension—Epirubicin—stomach cancer	0.000213	0.00212	CcSEcCtD
Metipranolol—Hypersensitivity—Capecitabine—stomach cancer	0.000213	0.00212	CcSEcCtD
Metipranolol—Myalgia—Epirubicin—stomach cancer	0.00021	0.0021	CcSEcCtD
Metipranolol—Anxiety—Epirubicin—stomach cancer	0.00021	0.00209	CcSEcCtD
Metipranolol—Discomfort—Epirubicin—stomach cancer	0.000208	0.00207	CcSEcCtD
Metipranolol—Asthenia—Capecitabine—stomach cancer	0.000208	0.00207	CcSEcCtD
Metipranolol—Propranolol—ADRB1—stomach cancer	0.000204	0.025	CrCbGaD
Metipranolol—Palpitations—Doxorubicin—stomach cancer	0.000202	0.00201	CcSEcCtD
Metipranolol—Oedema—Epirubicin—stomach cancer	0.000202	0.00201	CcSEcCtD
Metipranolol—Cough—Doxorubicin—stomach cancer	0.0002	0.00199	CcSEcCtD
Metipranolol—Dizziness—Docetaxel—stomach cancer	0.000198	0.00197	CcSEcCtD
Metipranolol—Hypertension—Doxorubicin—stomach cancer	0.000197	0.00197	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000196	0.00196	CcSEcCtD
Metipranolol—Myalgia—Doxorubicin—stomach cancer	0.000195	0.00194	CcSEcCtD
Metipranolol—Anxiety—Doxorubicin—stomach cancer	0.000194	0.00193	CcSEcCtD
Metipranolol—Discomfort—Doxorubicin—stomach cancer	0.000192	0.00192	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—stomach cancer	0.000192	0.00191	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—stomach cancer	0.000192	0.00191	CcSEcCtD
Metipranolol—Dizziness—Capecitabine—stomach cancer	0.000192	0.00191	CcSEcCtD
Metipranolol—Rash—Docetaxel—stomach cancer	0.000189	0.00188	CcSEcCtD
Metipranolol—Dermatitis—Docetaxel—stomach cancer	0.000188	0.00188	CcSEcCtD
Metipranolol—Headache—Docetaxel—stomach cancer	0.000187	0.00187	CcSEcCtD
Metipranolol—Oedema—Doxorubicin—stomach cancer	0.000187	0.00186	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000184	0.00183	CcSEcCtD
Metipranolol—Rash—Capecitabine—stomach cancer	0.000183	0.00182	CcSEcCtD
Metipranolol—Dermatitis—Capecitabine—stomach cancer	0.000182	0.00182	CcSEcCtD
Metipranolol—Propranolol—HTR1A—stomach cancer	0.000182	0.0224	CrCbGaD
Metipranolol—Headache—Capecitabine—stomach cancer	0.000181	0.00181	CcSEcCtD
Metipranolol—Dyspnoea—Epirubicin—stomach cancer	0.00018	0.00179	CcSEcCtD
Metipranolol—Somnolence—Epirubicin—stomach cancer	0.000179	0.00179	CcSEcCtD
Metipranolol—Nausea—Docetaxel—stomach cancer	0.000178	0.00177	CcSEcCtD
Metipranolol—Nausea—Capecitabine—stomach cancer	0.000172	0.00171	CcSEcCtD
Metipranolol—Propranolol—ADRB2—stomach cancer	0.000171	0.0211	CrCbGaD
Metipranolol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00017	0.00169	CcSEcCtD
Metipranolol—Dyspnoea—Doxorubicin—stomach cancer	0.000166	0.00166	CcSEcCtD
Metipranolol—Somnolence—Doxorubicin—stomach cancer	0.000166	0.00165	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—stomach cancer	0.000159	0.00158	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—stomach cancer	0.000155	0.00154	CcSEcCtD
Metipranolol—Hypersensitivity—Epirubicin—stomach cancer	0.000149	0.00148	CcSEcCtD
Metipranolol—Asthenia—Epirubicin—stomach cancer	0.000145	0.00144	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—stomach cancer	0.000143	0.00142	CcSEcCtD
Metipranolol—Hypersensitivity—Doxorubicin—stomach cancer	0.000138	0.00137	CcSEcCtD
Metipranolol—Rash—Methotrexate—stomach cancer	0.000136	0.00135	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—stomach cancer	0.000136	0.00135	CcSEcCtD
Metipranolol—Headache—Methotrexate—stomach cancer	0.000135	0.00134	CcSEcCtD
Metipranolol—Asthenia—Doxorubicin—stomach cancer	0.000134	0.00133	CcSEcCtD
Metipranolol—Dizziness—Epirubicin—stomach cancer	0.000133	0.00133	CcSEcCtD
Metipranolol—Nausea—Methotrexate—stomach cancer	0.000128	0.00127	CcSEcCtD
Metipranolol—Rash—Epirubicin—stomach cancer	0.000127	0.00127	CcSEcCtD
Metipranolol—Dermatitis—Epirubicin—stomach cancer	0.000127	0.00127	CcSEcCtD
Metipranolol—Headache—Epirubicin—stomach cancer	0.000126	0.00126	CcSEcCtD
Metipranolol—Dizziness—Doxorubicin—stomach cancer	0.000123	0.00123	CcSEcCtD
Metipranolol—Nausea—Epirubicin—stomach cancer	0.00012	0.00119	CcSEcCtD
Metipranolol—Rash—Doxorubicin—stomach cancer	0.000118	0.00117	CcSEcCtD
Metipranolol—Dermatitis—Doxorubicin—stomach cancer	0.000118	0.00117	CcSEcCtD
Metipranolol—Headache—Doxorubicin—stomach cancer	0.000117	0.00116	CcSEcCtD
Metipranolol—Nausea—Doxorubicin—stomach cancer	0.000111	0.0011	CcSEcCtD
Metipranolol—ADRB2—Arf6 signaling events—MET—stomach cancer	9.32e-06	0.0129	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—F2R—stomach cancer	8.45e-06	0.0117	CbGpPWpGaD
Metipranolol—ADRB1—Endothelin Pathways—NOS3—stomach cancer	7.81e-06	0.0108	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.77e-06	0.0108	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.74e-06	0.0107	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—RGS2—stomach cancer	7.6e-06	0.0105	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	7.57e-06	0.0105	CbGpPWpGaD
Metipranolol—ADRB2—Arf6 trafficking events—CDH1—stomach cancer	6.38e-06	0.00885	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—ADRB1—stomach cancer	6e-06	0.00833	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—KISS1R—stomach cancer	5.89e-06	0.00818	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—KISS1R—stomach cancer	5.76e-06	0.008	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.59e-06	0.00776	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	5.47e-06	0.00759	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—stomach cancer	5.18e-06	0.00719	CbGpPWpGaD
Metipranolol—ADRB1—Endothelin Pathways—MAPK1—stomach cancer	5.06e-06	0.00702	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	4.99e-06	0.00692	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—ADRB2—stomach cancer	4.97e-06	0.0069	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	4.88e-06	0.00677	CbGpPWpGaD
Metipranolol—ADRB2—Arf6 signaling events—EGFR—stomach cancer	4.72e-06	0.00655	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—stomach cancer	4.29e-06	0.00596	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HRH4—stomach cancer	4.26e-06	0.00591	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HRH4—stomach cancer	4.17e-06	0.00578	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—KISS1—stomach cancer	3.8e-06	0.00527	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.79e-06	0.00526	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.75e-06	0.0052	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—KISS1—stomach cancer	3.71e-06	0.00515	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	3.71e-06	0.00515	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	3.67e-06	0.00509	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.65e-06	0.00507	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	3.57e-06	0.00496	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	3.34e-06	0.00464	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—KISS1R—stomach cancer	3.33e-06	0.00462	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—KISS1R—stomach cancer	3.26e-06	0.00452	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	3.25e-06	0.00451	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	3.21e-06	0.00446	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	3.18e-06	0.00441	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	3.14e-06	0.00436	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	3.13e-06	0.00434	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	3.06e-06	0.00425	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—KISS1R—stomach cancer	3.02e-06	0.0042	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	3.02e-06	0.00419	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—KISS1R—stomach cancer	2.96e-06	0.0041	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	2.96e-06	0.0041	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.94e-06	0.00408	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	2.88e-06	0.00399	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	2.86e-06	0.00397	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	2.77e-06	0.00384	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—AGTR2—stomach cancer	2.47e-06	0.00343	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—F2R—stomach cancer	2.45e-06	0.0034	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—AGTR2—stomach cancer	2.42e-06	0.00336	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HRH4—stomach cancer	2.41e-06	0.00334	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—F2R—stomach cancer	2.39e-06	0.00332	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR1A—stomach cancer	2.38e-06	0.00331	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	2.37e-06	0.00329	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HRH4—stomach cancer	2.36e-06	0.00327	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR1A—stomach cancer	2.33e-06	0.00323	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—ANXA1—stomach cancer	2.3e-06	0.00319	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—ANXA1—stomach cancer	2.25e-06	0.00312	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HRH4—stomach cancer	2.19e-06	0.00303	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—ADRB1—stomach cancer	2.18e-06	0.00302	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—KISS1—stomach cancer	2.15e-06	0.00298	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HRH4—stomach cancer	2.14e-06	0.00297	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—KISS1—stomach cancer	2.1e-06	0.00291	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—KISS1—stomach cancer	1.95e-06	0.0027	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—KISS1—stomach cancer	1.91e-06	0.00265	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RGS2—stomach cancer	1.85e-06	0.00256	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GAST—stomach cancer	1.85e-06	0.00256	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—ADRB2—stomach cancer	1.81e-06	0.0025	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GAST—stomach cancer	1.81e-06	0.0025	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RGS2—stomach cancer	1.81e-06	0.0025	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GLI3—stomach cancer	1.79e-06	0.00248	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KISS1R—stomach cancer	1.79e-06	0.00248	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KISS1R—stomach cancer	1.75e-06	0.00242	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GLI3—stomach cancer	1.75e-06	0.00242	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RBP1—stomach cancer	1.7e-06	0.00236	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GAST—stomach cancer	1.68e-06	0.00233	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—RGS2—stomach cancer	1.68e-06	0.00233	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RBP1—stomach cancer	1.67e-06	0.00231	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RGS2—stomach cancer	1.64e-06	0.00227	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GAST—stomach cancer	1.64e-06	0.00227	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AGTR2—stomach cancer	1.4e-06	0.00194	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—WWOX—stomach cancer	1.39e-06	0.00193	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—F2R—stomach cancer	1.38e-06	0.00192	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AGTR2—stomach cancer	1.37e-06	0.0019	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—WWOX—stomach cancer	1.36e-06	0.00189	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—F2R—stomach cancer	1.35e-06	0.00188	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR1A—stomach cancer	1.35e-06	0.00187	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR1A—stomach cancer	1.32e-06	0.00183	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ANXA1—stomach cancer	1.3e-06	0.0018	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—WIF1—stomach cancer	1.29e-06	0.00179	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HRH4—stomach cancer	1.29e-06	0.00179	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ANXA1—stomach cancer	1.27e-06	0.00176	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AGTR2—stomach cancer	1.27e-06	0.00176	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HRH4—stomach cancer	1.26e-06	0.00175	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—WIF1—stomach cancer	1.26e-06	0.00175	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—F2R—stomach cancer	1.26e-06	0.00174	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	1.24e-06	0.00172	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	1.23e-06	0.00171	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	1.23e-06	0.0017	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	1.22e-06	0.0017	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	1.2e-06	0.00166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	1.19e-06	0.00165	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	1.18e-06	0.00164	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	1.17e-06	0.00162	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	1.15e-06	0.0016	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	1.15e-06	0.0016	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	1.15e-06	0.0016	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.15e-06	0.00159	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	1.13e-06	0.00156	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	1.13e-06	0.00156	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	1.12e-06	0.00155	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	1.12e-06	0.00155	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FST—stomach cancer	1.03e-06	0.00142	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	1.02e-06	0.00142	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	1e-06	0.00139	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FST—stomach cancer	1e-06	0.00139	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GAST—stomach cancer	9.9e-07	0.00137	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	9.9e-07	0.00137	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	9.82e-07	0.00136	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	9.68e-07	0.00134	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GAST—stomach cancer	9.68e-07	0.00134	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGG—stomach cancer	9.38e-07	0.0013	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	9.27e-07	0.00129	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGG—stomach cancer	9.18e-07	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	9.08e-07	0.00126	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	9.03e-07	0.00125	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	8.88e-07	0.00123	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	8.84e-07	0.00123	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	8.72e-07	0.00121	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	8.72e-07	0.00121	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	8.53e-07	0.00118	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	8.53e-07	0.00118	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	7.5e-07	0.00104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	7.5e-07	0.00104	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	7.42e-07	0.00103	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—F2R—stomach cancer	7.42e-07	0.00103	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	7.34e-07	0.00102	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	7.34e-07	0.00102	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	7.3e-07	0.00101	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	7.26e-07	0.00101	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—F2R—stomach cancer	7.26e-07	0.00101	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	7.22e-07	0.001	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	7.14e-07	0.000991	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	7.06e-07	0.00098	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	6.99e-07	0.00097	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	6.97e-07	0.000968	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	6.84e-07	0.000949	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	6.82e-07	0.000947	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	6.61e-07	0.000917	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	6.45e-07	0.000895	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	6.35e-07	0.000881	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	6.32e-07	0.000878	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	6.31e-07	0.000876	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	6.21e-07	0.000862	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	6.19e-07	0.000858	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	5.93e-07	0.000823	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	5.8e-07	0.000805	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	5.64e-07	0.000783	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	5.61e-07	0.000779	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	5.52e-07	0.000766	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	5.49e-07	0.000762	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	5.47e-07	0.000759	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	5.36e-07	0.000744	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	5.25e-07	0.000728	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	5.1e-07	0.000707	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	4.99e-07	0.000692	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	4.98e-07	0.000691	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	4.93e-07	0.000684	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	4.87e-07	0.000676	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	4.82e-07	0.000669	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FYN—stomach cancer	4.73e-07	0.000656	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FYN—stomach cancer	4.63e-07	0.000642	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	4.47e-07	0.000621	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	4.44e-07	0.000616	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	4.38e-07	0.000607	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	4.34e-07	0.000602	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	4.06e-07	0.000564	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	3.98e-07	0.000552	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	3.94e-07	0.000547	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	3.93e-07	0.000546	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	3.86e-07	0.000535	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	3.85e-07	0.000534	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	3.75e-07	0.00052	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	3.74e-07	0.000518	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	3.67e-07	0.000509	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	3.65e-07	0.000507	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APC—stomach cancer	3.59e-07	0.000498	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APC—stomach cancer	3.51e-07	0.000487	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	3.44e-07	0.000477	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	3.36e-07	0.000467	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	3.33e-07	0.000462	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	3.27e-07	0.000454	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	3.27e-07	0.000454	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	3.26e-07	0.000452	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	3.2e-07	0.000444	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	3.2e-07	0.000444	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	3.13e-07	0.000434	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	3.12e-07	0.000433	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	3.09e-07	0.000429	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	3.06e-07	0.000424	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	3.05e-07	0.000424	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	3.02e-07	0.000419	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	3.01e-07	0.000418	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	2.98e-07	0.000413	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	2.95e-07	0.000409	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	2.92e-07	0.000404	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	2.84e-07	0.000394	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	2.79e-07	0.000387	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	2.78e-07	0.000385	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	2.73e-07	0.000378	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	2.64e-07	0.000367	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	2.63e-07	0.000364	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	2.59e-07	0.000359	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	2.58e-07	0.000358	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	2.57e-07	0.000356	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	2.53e-07	0.00035	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	2.51e-07	0.000349	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	2.46e-07	0.000342	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	2.46e-07	0.000341	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—JUN—stomach cancer	2.46e-07	0.000341	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	2.41e-07	0.000334	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—JUN—stomach cancer	2.4e-07	0.000334	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	2.39e-07	0.000332	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	2.38e-07	0.000331	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	2.34e-07	0.000325	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	2.33e-07	0.000323	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	2.33e-07	0.000323	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	2.27e-07	0.000316	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.15e-07	0.000298	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.13e-07	0.000295	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.1e-07	0.000291	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.08e-07	0.000289	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.03e-07	0.000282	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	1.99e-07	0.000276	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MYC—stomach cancer	1.98e-07	0.000274	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	1.93e-07	0.000268	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MYC—stomach cancer	1.93e-07	0.000268	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	1.93e-07	0.000268	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	1.89e-07	0.000262	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	1.89e-07	0.000262	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.83e-07	0.000253	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.79e-07	0.000248	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.68e-07	0.000233	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	1.64e-07	0.000228	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TP53—stomach cancer	1.62e-07	0.000225	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TP53—stomach cancer	1.59e-07	0.00022	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	1.55e-07	0.000215	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	1.52e-07	0.000211	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.48e-07	0.000206	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.45e-07	0.000202	CbGpPWpGaD
